CAMP4 Enters Strategic Research Collaboration to Advance
• Collaboration combines BioMarin’s expertise in drug development with CAMP4’s platform-based target discovery capabilities • CAMP4 to receive upfront payment, with...
Advance
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics Enters into a joint research agreement with the Chinese drug discovery platform company "HitGen" to accelerate the discovery...
